Literature DB >> 32040179

High prevalence of Escherichia coli clinical isolates in India harbouring four amino acid inserts in PBP3 adversely impacting activity of aztreonam/avibactam.

Hariharan Periasamy1, Prashant Joshi1, Snehal Palwe1, Rahul Shrivastava1, Sachin Bhagwat1, Mahesh Patel1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32040179     DOI: 10.1093/jac/dkaa021

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  8 in total

Review 1.  Is it time to move away from polymyxins?: evidence and alternatives.

Authors:  Rajeev Soman; Yamuna Devi Bakthavatchalam; Abinaya Nadarajan; Hariharan Triplicane Dwarakanathan; Ramasubramanian Venkatasubramanian; Balaji Veeraraghavan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-10-02       Impact factor: 3.267

Review 2.  New β-Lactam-β-Lactamase Inhibitor Combinations.

Authors:  Dafna Yahav; Christian G Giske; Alise Grāmatniece; Henrietta Abodakpi; Vincent H Tam; Leonard Leibovici
Journal:  Clin Microbiol Rev       Date:  2020-11-11       Impact factor: 26.132

Review 3.  OXA-48-Like β-Lactamases: Global Epidemiology, Treatment Options, and Development Pipeline.

Authors:  Sara E Boyd; Alison Holmes; Richard Peck; David M Livermore; William Hope
Journal:  Antimicrob Agents Chemother       Date:  2022-07-20       Impact factor: 5.938

4.  Genetic Features Leading to Reduced Susceptibility to Aztreonam-Avibactam among Metallo-β-Lactamase-Producing Escherichia coli Isolates.

Authors:  Mustafa Sadek; Mario Juhas; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2020-11-17       Impact factor: 5.191

5.  Activity of Aztreonam in Combination with Avibactam, Clavulanate, Relebactam, and Vaborbactam against Multidrug-Resistant Stenotrophomonas maltophilia.

Authors:  M Biagi; D Lamm; K Meyer; A Vialichka; M Jurkovic; S Patel; R E Mendes; Z P Bulman; E Wenzler
Journal:  Antimicrob Agents Chemother       Date:  2020-11-17       Impact factor: 5.191

6.  Investigation of mechanisms responsible for decreased susceptibility of aztreonam/avibactam activity in clinical isolates of Enterobacterales collected in Europe, Asia and Latin America in 2019.

Authors:  Rodrigo E Mendes; Timothy B Doyle; Jennifer M Streit; Francis F Arhin; Helio S Sader; Mariana Castanheira
Journal:  J Antimicrob Chemother       Date:  2021-10-11       Impact factor: 5.790

7.  Differences in the Distribution of Species, Carbapenemases, Sequence Types, Antimicrobial Heteroresistance and Mortality Rates Between Pediatric and Adult Carbapenemase-Producing Enterobacterales in Bloodstream Infections.

Authors:  Hanbing Yu; Deyu Ma; Bo Liu; Suqing Yang; Qiuxia Lin; Renlin Yu; Xiaojiong Jia; Siqiang Niu; Qun Zhang; Shifeng Huang
Journal:  Front Med (Lausanne)       Date:  2022-03-14

8.  Occurrence of Aztreonam-Avibactam-Resistant NDM-5-Producing Escherichia coli in the Food Chain.

Authors:  Mustafa Sadek; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2021-08-17       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.